|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development |
| 1. |
Hemobiotech Inc.
|
|
|
Developer of blood substitute, aiming to address intrinsic hemoglobin toxicity. Introduction to company and their work, with form to contact Dallas, Texas.
|
| 2. |
Xencor, Inc.
|
|
|
Technology for MHC epitope removal, glycosylation to optimize pharmacokinetics, masking immune recognition sites and engineering monoclonal antibodies. Includes discovery programs, partnering opportunities in Monrovia, California. ImmunoPDAa?? Technology Product Sheet Caltech spin-off developing proteomic technologies to accelerate drug discovery.
|
| 3. |
Mixture Sciences, Inc.
|
|
|
A privately held company that specializes in research for treatment of cancer, diabetes, multiple sclerosis, HIV/AIDS and infectious diseases, including Lyme Disease. Lists research projects and procedures. Based in San Diego, California.
|
| 4. |
EntreMed, Inc.
|
|
|
Researches and develops biopharmaceutical products which address the role of blood and blood vessels in the prevention and treatment of diseases by inhibiting growth or enhancing bioavailability of drugs. Based in Rockville, Maryland. (Nasdaq: ENMD)
|
| 5. |
ZymoGenetics, Inc.
|
|
|
Discovery, development and commercialization of therapeutic proteins for the prevention and treatment of human diseases. Includes product pipeline, news on clinical trials and profile of company in Seattle, Washington.
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
